Rockport Wealth’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Rockport Wealth’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,000	Closed	-$203K	–	100
2025 Q2	$203K	Buy	+5,000	New	+$201K	0.05%	84
2024 Q4	–	Sell	-27,500	Closed	-$1.22M	–	76
2024 Q3	$1.22M	Sell	27,500 -18,070	-40%	-$774K	0.33%	29
2024 Q2	$1.81M	Buy	+45,570	New	+$1.85M	0.77%	18

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Rockport Wealth's XPH Position: Q3 2025 in Review

Rockport Wealth sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2025, closing a stake of 5,000 shares — an estimated $203K sold.

Rockport Wealth first reported a position in XPH in Q2 2024 and held it in 3 quarters. The position peaked at $1.81M in Q2 2024. 69 funds tracked by Wall St. Rank hold XPH as of Q3 2025.

Rockport Wealth reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
Rockport Wealth sold 5,000 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2025, an estimated $203K.
Rockport Wealth first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2024 and held it in 3 quarters.
Rockport Wealth's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.81M in Q2 2024.
69 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2025.

Based on Rockport Wealth's 13F filing for Q3 2025, filed 31 Oct 2025.